183 related articles for article (PubMed ID: 1571680)
21. Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil.
Borges SZ; Bakos L; Cartell A; Wagner M; Agostini A; Lersch E
Int J Dermatol; 2007 Jul; 46(7):679-86. PubMed ID: 17614794
[TBL] [Abstract][Full Text] [Related]
22. Trends in incidence of thick, thin and in situ melanoma in Europe.
Sacchetto L; Zanetti R; Comber H; Bouchardy C; Brewster DH; Broganelli P; Chirlaque MD; Coza D; Galceran J; Gavin A; Hackl M; Katalinic A; Larønningen S; Louwman MWJ; Morgan E; Robsahm TE; Sanchez MJ; Tryggvadóttir L; Tumino R; Van Eycken E; Vernon S; Zadnik V; Rosso S
Eur J Cancer; 2018 Mar; 92():108-118. PubMed ID: 29395684
[TBL] [Abstract][Full Text] [Related]
23. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
[TBL] [Abstract][Full Text] [Related]
24. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011.
Bay C; Kejs AM; Storm HH; Engholm G
Cancer Epidemiol; 2015 Feb; 39(1):1-7. PubMed ID: 25468643
[TBL] [Abstract][Full Text] [Related]
25. Epidemiological changes in cutaneous melanoma: retrospective study of 969 cases (1996-2010).
Avilés-Izquierdo JA; Lázaro-Ochaita P; Suárez-Fernández R; Márquez-Rodas I; Parra-Blanco V; Escat-Cortés JL
Rev Clin Esp (Barc); 2013 Mar; 213(2):81-7. PubMed ID: 22874464
[TBL] [Abstract][Full Text] [Related]
26. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.
Downing A; Newton-Bishop JA; Forman D
Br J Cancer; 2006 Jul; 95(1):91-5. PubMed ID: 16755289
[TBL] [Abstract][Full Text] [Related]
27. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
28. Are all melanomas dangerous?
Nørgaard C; Glud M; Gniadecki R
Acta Derm Venereol; 2011 Sep; 91(5):499-503. PubMed ID: 21874217
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
30. Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in Western Netherlands, 1980-95.
van der Rhee HJ; van der Spek-Keijser LM; van Westering R; Coebergh JW
Br J Dermatol; 1999 Mar; 140(3):463-7. PubMed ID: 10233267
[TBL] [Abstract][Full Text] [Related]
31. Changes in the site distribution of malignant melanoma in South East Scotland (1979-2002).
Mowbray M; Stockton DL; Doherty VR
Br J Cancer; 2007 Mar; 96(5):832-5. PubMed ID: 17299392
[TBL] [Abstract][Full Text] [Related]
32. Factors related to the presentation of patients with thick primary melanomas.
Hersey P; Sillar RW; Howe CG; Burton RC; Darbar SV; Foster HM; Collins SM; Bradley DE; Owens D
Med J Aust; 1991 May; 154(9):583-7. PubMed ID: 2056943
[TBL] [Abstract][Full Text] [Related]
33. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
Sassen S; Shaw HM; Colman MH; Scolyer RA; Thompson JF
Ann Surg Oncol; 2008 Feb; 15(2):630-7. PubMed ID: 18080717
[TBL] [Abstract][Full Text] [Related]
34. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
[TBL] [Abstract][Full Text] [Related]
35. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
[TBL] [Abstract][Full Text] [Related]
36. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
Crocetti E; Carli P
Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
[TBL] [Abstract][Full Text] [Related]
37. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
Downing A; Yu XQ; Newton-Bishop J; Forman D
Int J Cancer; 2008 Aug; 123(4):861-6. PubMed ID: 18500743
[TBL] [Abstract][Full Text] [Related]
38. Retrospective study on the cutaneous head and neck melanoma in Dorset (UK).
Komisarovas L; Jayasinghe C; Seah TE; Ilankovan V
Br J Oral Maxillofac Surg; 2011 Jul; 49(5):359-63. PubMed ID: 20678832
[TBL] [Abstract][Full Text] [Related]
39. Clinical stages of cutaneous malignant melanoma in Bulgaria.
Troyanova P; Valerianova Z; Danon S
Neoplasma; 2000; 47(4):257-60. PubMed ID: 11043833
[TBL] [Abstract][Full Text] [Related]
40. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
Einwachter-Thompson J; MacKie RM
Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
